Pages that link to "Q73437260"
Jump to navigation
Jump to search
The following pages link to Changes in breast density associated with initiation, discontinuation, and continuing use of hormone replacement therapy (Q73437260):
Displaying 50 items.
- Red-clover-derived isoflavones and mammographic breast density: a double-blind, randomized, placebo-controlled trial [ISRCTN42940165] (Q24794752) (← links)
- Mammographic breast density as a biomarker of effects of isoflavones on the female breast (Q24802055) (← links)
- Percentage density, Wolfe's and Tabár's mammographic patterns: agreement and association with risk factors for breast cancer (Q24813796) (← links)
- Vitamin D and mammographic breast density: a systematic review (Q26864446) (← links)
- Quantitative Assessment of Mammographic Breast Density: Relationship with Breast Cancer Risk (Q30311964) (← links)
- Histologic changes in the breast with menopausal hormone therapy use: correlation with breast density, estrogen receptor, progesterone receptor, and proliferation indices (Q30370870) (← links)
- Breast tissue composition and susceptibility to breast cancer (Q30474496) (← links)
- Quantitative Magnetization Transfer Imaging of the Breast at 3.0 T: Reproducibility in Healthy Volunteers. (Q31154821) (← links)
- Mammographic density (Q33555460) (← links)
- Short-term hormone therapy suspension and mammography recall: a randomized trial (Q33577256) (← links)
- Stroma in breast development and disease. (Q33663923) (← links)
- Mammographic density and survival in interval breast cancers (Q33739464) (← links)
- Mammographic breast density--evidence for genetic correlations with established breast cancer risk factors (Q33745464) (← links)
- Nonsteroidal anti-inflammatory drugs and change in mammographic density: a cohort study using pharmacy records on over 29,000 postmenopausal women (Q33811534) (← links)
- Alcohol intake over the life course and mammographic density (Q33811546) (← links)
- Evaluation of expert criteria for preoperative magnetic resonance imaging of newly diagnosed breast cancer (Q33819423) (← links)
- Collagen density promotes mammary tumor initiation and progression (Q33845553) (← links)
- Breast cancer risk by breast density, menopause, and postmenopausal hormone therapy use (Q34131826) (← links)
- Mammographic breast density and tolerance for short-term postmenopausal hormone therapy suspension (Q34137122) (← links)
- Mammographic densities as a marker of human breast cancer risk and their use in chemoprevention. (Q34272022) (← links)
- Tracking progesterone receptor-mediated actions in breast cancer (Q34388848) (← links)
- The meaning of mammographic breast density in users of postmenopausal hormone therapy (Q34557217) (← links)
- Mammographic tissue, breast cancer risk, serial image analysis, and digital mammography. Part 2. Serial breast tissue change and related temporal influences (Q34558085) (← links)
- Altered AIB1 or AIB1Δ3 Expression Impacts ERα Effects on Mammary Gland Stromal and Epithelial Content (Q34712100) (← links)
- Postmenopausal hormone replacement therapy: effects on normal mammary gland in humans and in a mouse postmenopausal model (Q34771470) (← links)
- Hormone replacement therapy and surveillance considerations (Q34935126) (← links)
- Mammographic density in birth cohorts of Danish women: a longitudinal study (Q35012390) (← links)
- Hormone metabolism pathway genes and mammographic density change after quitting estrogen and progestin combined hormone therapy in the California Teachers Study (Q35052877) (← links)
- Influence of lifestyle factors on mammographic density in postmenopausal women (Q35069831) (← links)
- Prognostic significance of mammographic density change after initiation of tamoxifen for ER-positive breast cancer (Q35102667) (← links)
- Discovery of breast cancers within 1 year of a normal screening mammogram: how are they found? (Q35205505) (← links)
- Breast cancer risk factors in relation to breast density (United States). (Q35230186) (← links)
- HRT: Decide Based on the Evidence (Q35539421) (← links)
- Association between high-sensitivity C-reactive protein (hsCRP) and change in mammographic density over time in the SWAN mammographic density subcohort. (Q35733402) (← links)
- Relationship between breast cancer risk factors and mammographic breast density in the Fernald Community Cohort (Q35835198) (← links)
- Postmenopausal hormone therapy and breast cancer: a clinician's message for patients (Q38638658) (← links)
- Awareness of breast density and its impact on breast cancer detection and risk (Q36002291) (← links)
- The influence of statin use on breast density (Q36121798) (← links)
- No evidence for association of inherited variation in genes involved in mitosis and percent mammographic density (Q36393107) (← links)
- Clinical opinion: the biologic and pharmacologic principles for age-adjusted long-term estrogen therapy (Q36568449) (← links)
- Body mass index, tumor characteristics, and prognosis following diagnosis of early-stage breast cancer in a mammographically screened population (Q36569214) (← links)
- Diet across the Lifespan and the Association with Breast Density in Adulthood (Q36616170) (← links)
- Modeling prolactin actions in breast cancer in vivo: insights from the NRL-PRL mouse (Q36629985) (← links)
- Mammographic density. Potential mechanisms of breast cancer risk associated with mammographic density: hypotheses based on epidemiological evidence (Q36643000) (← links)
- The association of breast mitogens with mammographic densities (Q36646178) (← links)
- Mammographic breast density response to aromatase inhibition (Q36778183) (← links)
- Physical activity and mammographic breast density: a systematic review (Q36809004) (← links)
- Reproducibility of BI-RADS breast density measures among community radiologists: a prospective cohort study (Q36862786) (← links)
- A "Spontaneously Shrinking" Breast Mass: Unusual Presentation of Invasive Tubular Carcinoma (Q36964248) (← links)
- Outcomes of screening mammography by frequency, breast density, and postmenopausal hormone therapy (Q36976948) (← links)